About
Perfuze is an Irish medical device company founded in 2018 and based in Galway City, Ireland. The company focuses on developing advanced catheter-based technologies for treating acute ischemic stroke, aiming to enhance patient outcomes through innovative solutions. Their core product is the Millipede 088 catheter, designed for superior aspiration performance during mechanical thrombectomy procedures. This technology simplifies vascular access and improves clot removal efficiency and safety. Perfuze is also engaged in ongoing clinical research and regulatory activities to secure approvals and expand the indications for their devices, including participation in studies like the MARRS IDE Study. Perfuze targets healthcare providers in neurovascular interventions, including hospitals and stroke centers. Their customers consist of interventional neuroradiologists, neurosurgeons, and interventional neurologists. With backing from investment funds and a strategic vision for growth, Perfuze aims to expand its product pipeline and innovate future stroke treatment technologies.
Technologies
Keywords
Company Information
-
Employees 39
-
Founded 2018
-
Annual Revenue $4300000
-
Total Funding $57608086
Location
Dangan Court, Galway, County Galway, Ireland